Evidence map›Paper›PMID 28515047›Full record

ReviewEndocrine-related cancer2017

Centrosome amplification: a suspect in breast cancer and racial disparities.

Angela Ogden, Padmashree C G Rida, Ritu Aneja

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrine-related cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The roles of centrosome amplification in diabetes-associated diseases.Frontiers in cell and developmental biology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Angela OgdenDepartment of BiologyGeorgia State University, Atlanta, Georgia, USA.
Padmashree C G RidaDepartment of BiologyGeorgia State University, Atlanta, Georgia, USA.
Ritu AnejaDepartment of BiologyGeorgia State University, Atlanta, Georgia, USA raneja@gsu.edu.
Georgia State University · US

Funding

Evaluation of HSET as a Novel Theranostic Target for Breast Cancer TherapyR01CA169127 · NCI · GEORGIA STATE UNIVERSITY · PI ANEJA, RITU · 2012 to 2016
$1.7M
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggrU01CA179671 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANEJA, RITU · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA169127NCI NIH HHS U01 CA179671
6 · The paper itself

Abstract

The multifaceted involvement of centrosome amplification (CA) in tumorigenesis is coming into focus following years of meticulous experimentation, which have elucidated the powerful abilities of CA to promote cellular invasion, disrupt stem cell division, drive chromosomal instability (CIN) and perturb tissue architecture, activities that can accelerate tumor progression. Integration of the extant

Indexed as

CentrosomeAnimalsBreast NeoplasmsHumansRacial Groupsbreastcarcinoma

Identifiers

PMID28515047
PMCPMC5837860
OpenAlexW2615203396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.